BlackRock Institutional Trust’s Flexion Therapeutics, Inc. FLXN Stock Holding History

BlackRock Institutional Trust’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$13M	Buy	683,076 +220,150	+48%	+$4.21M	﹤0.01%	2248
2016 Q3	$9.05M	Buy	462,926 +162,520	+54%	+$2.75M	﹤0.01%	2391
2016 Q2	$4.5M	Buy	300,406 +28,459	+10%	+$358K	﹤0.01%	2730
2016 Q1	$2.5M	Sell	271,947 -2,681	-1%	-$32.5K	﹤0.01%	2958
2015 Q4	$5.29M	Buy	274,628 +6,739	+3%	+$117K	﹤0.01%	2693
2015 Q3	$3.98M	Buy	267,889 +162,068	+153%	+$3.8M	﹤0.01%	2826
2015 Q2	$2.32M	Buy	105,821 +47,190	+80%	+$952K	﹤0.01%	3059
2015 Q1	$1.32M	Buy	58,631 +12,412	+27%	+$287K	﹤0.01%	3263
2014 Q4	$933K	Buy	46,219 +8,731	+23%	+$158K	﹤0.01%	3374
2014 Q3	$685K	Sell	37,488 -4,248	-10%	-$61.5K	﹤0.01%	3428
2014 Q2	$563K	Sell	41,736 -330	-0.8%	-$4.5K	﹤0.01%	3539
2014 Q1	$692K	Buy	+42,066	New	+$727K	﹤0.01%	3515

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

BlackRock Institutional Trust's FLXN Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Flexion Therapeutics, Inc. (FLXN) stake by 48% in Q4 2016, buying an estimated $4.21M and bringing the position to 683,076 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

BlackRock Institutional Trust first reported a position in FLXN in Q1 2014 and has held it in 12 quarters since. 94 funds tracked by Wall St. Rank hold FLXN as of Q4 2016.

BlackRock Institutional Trust held 683,076 shares of Flexion Therapeutics, Inc. worth $13M as of Q4 2016.
BlackRock Institutional Trust bought 220,150 Flexion Therapeutics, Inc. shares in Q4 2016, an estimated $4.21M.
Flexion Therapeutics, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2248 holding.
BlackRock Institutional Trust first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and has held it in 12 quarters since.
94 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.